NICE unveils guidelines to monitor antibiotic prescribing
February 18, 2015Sales and Marketing AMR, Antibiotics, GPs, NHS, NICE, antimicrobials, baker
NICE are asking UK doctors to spy on their colleagues in order to help tackle the growing threat of antimicrobial …
Tonic Life Communications hires three
February 18, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ainsley cooper, alex davies, appointments, elisabeth neal, tonic life communications
Healthcare comms consultancy Tonic Life Communications has added three new senior heads to increase its London team. The news follows …
Cipla sets up new plant in Morocco
February 17, 2015Manufacturing and Production, Sales and Marketing Cooper Pharma, PHI, PHI), Societe Marocaine De Cooperation Pharmaceutique, The Pharmaceutical Institute, cipla. morocco
Indian firm Cipla’s UK subsidiary has entered into a joint venture to establish a stronger presence in Morocco, as it …
Takeda trial hits late-stage buffers
February 17, 2015Research and Development, Sales and Marketing AMG 706, Japan, NSCLC, Takeda, lung cancer, motesanib
Takeda is to scrap an advanced trial of an investigational drug after it failed to show any benefit in survival …
Several board changes at AstraZeneca
February 17, 2015Sales and Marketing AstraZeneca, Bruce Burlington, Cornelia Bargmann, Graham Chipchase, Rudy Markham
AstraZeneca is conducting a boardroom overhaul as it announces non-executive board changes and retirements ahead of its annual meeting in …
New comms director for Royal College of Surgeons
February 17, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing RCS, royal college of surgeons, simon edwards
The Royal College of Surgeons has promoted Simon Edwards to the position of director of communications. Edwards previously held the …
Hospira launches biosimilar monoclonal antibody
February 16, 2015Research and Development, Sales and Marketing MSD, Merck, Remicade, biosimilar. hospira, inflectra, infliximab
Hospira has won the race to become the first company to launch a biosimilar version of an anti-TNF biologic, after …
Shire delivers record revenues
February 16, 2015Sales and Marketing ADHD, AbbVie, Shire, Viropharma, Vyvanse, intuniv, lialda
Shire has posted strong growth in its full-year results, showing that the company is faring well even after the collapse …
FDA approves Eisai thyroid drug, fast-tracks Novartis heart pill
February 16, 2015Sales and Marketing Eisai, FDA, LCZ696, Lenvima, Novartis, heart, lenvatinib, thyroid
The FDA has approved Eisai’s thyroid cancer drug Lenvima and also granted Novartis heart pill LCZ696 a priority review. Lenvima …
AstraZeneca loses US Pulmicort patent
February 16, 2015Sales and Marketing AstraZeneca, Budesonide Inhalation Suspension, asthma, pulmicourt, respiratory
British drugmaker AstraZeneca has been dealt a blow by the courts in the US, after a district judge ruled its …
Onyx Health appoints account manager
February 16, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Onyx, dean forbes
UK healthcare marketing communications firm experts Onyx Health have hired Dean Forbes to develop their marketing, PR and branding services. …
Big Data has yet to hit the big time
February 16, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Big Data, chris poole, data, development, mark thornton
Big data has taken quite a knocking over the past year. First, from some sceptics who have warned big data …
TiGenix and Lonza partner on stem cell manufacturing
February 13, 2015Manufacturing and Production, Sales and Marketing Crohn’s disease, Lonza, Stem cells, TiGenix, crohn's disease, eascs, manufacturing, spa
Stem cell therapy developer TiGenix has enlisted the help of biologics manufacturer Lonza to produce its medicine Cx601 for late-stage …
Hormone replacement therapy elevates ovarian cancer risk
February 13, 2015Research and Development, Sales and Marketing Cancer, HRT, Lancet, Oxford, oncology, ovarian
According to a new study women who undergo hormone replacement therapy nearly double their risk of developing ovarian cancer. Findings …
Celgene’s blood cancer pill too expensive for NHS
February 13, 2015Sales and Marketing Celgene, NHS, NICE, Pomalidomide, imnovid, myeloma
NICE has decided not to recommend Celgene’s Imnovid for treating patients with multiple myeloma – a cancer that affects white …
Boehringer and Sanofi admit to code breaches
February 13, 2015Medical Communications, Sales and Marketing ABPI, Boehringer, PMCPA, Sanofi, afatinib, giotrif
Sanofi and Boehringer Ingelheim have both admitted to breaching the ABPI Code of Practice, with Sanofi set to be publicly …
Sanofi makes gene therapy move
February 13, 2015Research and Development, Sales and Marketing Genzyme, Sanofi, Voyager Therapeutics, gene therapy, merger
Sanofi has signalled its intent to develop gene therapy treatments for nerve diseases through a $745 million deal with US …
New director at IMC Healthcare Communication
February 13, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing imc healthcare communication, stephanie westwood
Dr Stephanie Westwood has joined IMC Healthcare Communication as a medical and scientific director. Westwood was previously a scientific director …
Google search results to include health facts
February 12, 2015Medical Communications, Sales and Marketing digital, google, health, internet, knowledge graph, wearables
Google is set to introduce health information directly into its search results as increasing numbers of people use search engines …
Websites selling illegal drugs increasingly face closure
February 12, 2015Manufacturing and Production, Medical Communications, Sales and Marketing MHRA, counterfeit, drugs, illegal, on tap, websites
The number of websites shut down by the MHRA for selling illegal pharmaceutical products has increased dramatically in recent years, …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
